Mindray Medical International, a mainland blood analysis machine maker, has filed for a US$276 million initial public offering on the New York Stock Exchange.
The filing came as New Oriental Education & Technology Group, a language-learning firm, priced its shares in New York above the indicative range, raising US$112.5 million, market sources said.
Mindray, the largest maker of blood pressure and blood oxygen-level monitoring equipment in China, offered no timetable for the share sale.
New rules from Beijing that go into effect today, overseeing the transfer of assets overseas, could delay the offering, the company said in a filing with the US Securities and Exchange Commission.
Beijing is trying to curtail the sale of assets overseas at prices many consider too cheap.
Net revenues at Shenzhen-based Mindray rose to 1.4 billion yuan last year from 460 million yuan in 2003. That represents a compound annual growth rate of 53 per cent.